Trials / Completed
CompletedNCT04285281
Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome
Oral Gabapentin and Median Nerve Neural Mobilization Versus Control in the Treatment of Carpal Tunnel Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Universidad Europea de Madrid · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The present randomized clinical trial will perform a comparison of the pain reduction effects produced by the application of a non invasive and non pharmacological median nerve neural mobilization (physiotherapy treatment), to those effects produced by Gabapentin and the absence of treatment, in subjects who suffer the signs and symptoms of carpal tunnel syndrome.
Detailed description
The present randomized clinical trial will perform a comparison of the pain reduction effects produced by the application of a non invasive and non pharmacological median nerve neural mobilization (physiotherapy treatment), to those effects produced by Gabapentin and the absence of treatment, in subjects who suffer the signs and symptoms of carpal tunnel syndrome. Additionally, effects over the functionality of the affected upper limb will be evaluated and compared. Subjects will be invited to participate and randomly allocated to 3 different groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin oral capsules | Oral capsule pharmaceutical treatment. |
| OTHER | Median nerve neural mobilization | Manual therapy maneuver performed in the upper limb. |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2020-08-01
- Completion
- 2020-08-10
- First posted
- 2020-02-26
- Last updated
- 2025-12-10
Locations
1 site across 1 country: Venezuela
Source: ClinicalTrials.gov record NCT04285281. Inclusion in this directory is not an endorsement.